Here are four things to know:
1. Dr. Friedman was president and CEO of Duarte, Calif.-based City of Hope, a research, treatment and education institution.
2. From 1997 until 1999, Dr. Friedman served as acting commissioner and lead deputy commissioner of operations for the FDA.
3. He has also served on the board of directors of Celgene Corporation since February 2011 and of Smith & Nephew since April 2013.
4. Dr. Friedman earned a doctorate in medicine from the Austin-based University of Texas. He completed postdoctoral training at Palo Alto-based Stanford University and the National Cancer Institute.
More articles on devices:
Bacterin acquires X-spine, becomes Xtant Medical — 7 things to know
InVivo CEO plans big: 5 key notes on capturing the spinal injury market
DJO Global net sales down 1%: 10 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
